Clinical Trials Logo

Clinical Trial Summary

Open label randomized controlled clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in treating left ventricular thrombus in patients with acute or recent myocardial infarction (MI).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05208398
Study type Interventional
Source Saud Al Babtain Cardiac Center
Status Completed
Phase Phase 3
Start date February 18, 2018
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT05892042 - Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction N/A
Recruiting NCT05973188 - Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial Phase 4
Recruiting NCT04970576 - Rivaroxaban in Left Ventricular Thrombus Phase 4
Not yet recruiting NCT03415386 - Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus Phase 4
Recruiting NCT05794399 - Anticoagulation in Post MI LV Thrombus Trial in Nepal Phase 4
Completed NCT05705089 - Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI Phase 3
Not yet recruiting NCT06152939 - Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy
Completed NCT04871126 - Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction
Recruiting NCT03764241 - Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant Phase 3
Recruiting NCT04829825 - The "MyoThrombus" Study
Not yet recruiting NCT03786757 - Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Phase 3